Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.

Shernan Holtan, MD, has been named the recipient of 2025 Lukas D. Wartman Award. Holtan, chief of blood and marrow ...

A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.

In developed countries, hematological malignancies (HM) account for 8 to 10% of cancers diagnosed annually and one-third of patients with HM (HMP) are expected to die from their disease. The former ...

Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...

Breast cancer survivors who developed incident myocardial infarction or heart failure exhibited increased risk for adverse oncologic outcomes, according to a population-based cohort study.The findings ...

Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...

The Centers for Disease Control and Prevention report the life-shortening blood disease sickle cell anemia affects about ...

Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin treatment were associated with improved PFS in ...

All patients in both treatment arms completed the 20-week double-blind period of the study. In the 20-week double-blind period of the study, similar proportion of patients had adverse events (AEs) in ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...